Noticias y Actividades de Venus Concept

Venus Concept es una empresa que cotiza bajo el símbolo de cotización VERO (CA).

Ver el organigrama con sus 24 ejecutivos principales

Biografías más buscadas en Venus Concept

• Rajiv De Silva, Chief Executive Officer and Director
• Keith Sullivan, Director
• Tyler Hollmig, Director

Recientes movimientos de ejecutivos en Venus Concept

• Hemanth Varghese, President and Chief Operating Officer, abandonará la empresa el 28 de mar.. de 2025  (noticia publicada el 26 de febrero de 2025).
• Ross Portaro que ha sido Executive Vice President and General Manager, Sales and Marketing, ha ascendido a Executive Vice President, Commercial Strategy and Head of Venus Hair  (noticia publicada el 26 de febrero de 2025).
• Kirk Gunhus, se ha incorporado a la empresa como Chief Revenue Officer  (noticia publicada el 26 de febrero de 2025).

Crear su alerta
para seguir los movimientos de los ejecutivos en Venus Concept.

Venus Concept tiene 1.828 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Eli Lilly (Estados Unidos).

Popular M&A news in Farmacia

• Chimerix and Chimerix have merged  (publicado el 22 de abril de 2025)..
• Imbria Pharmaceuticals acaba de anunciar una recaudación de fondos de 58 millones de dólares. (publicado el 10 de abril de 2025).
• Clario ha NRx Pharmaceuticals adquirido (publicado el 18 de marzo de 2025).

Otros contactos sugeridos en el sector Farmacia

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets en Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer en Adare Pharmaceuticals
• Seth Harrison - Chairman and Director en Braeburn Pharmaceuticals

Saber más sobre el sector Farmacia

Últimos comunicados de prensa de Venus Concept

• Venus Concept to Release Second Quarter of Fiscal Year 2022 Financial Results on August 12, 2022 | Venus Concept
• Venus Concept Announces First Quarter of Fiscal Year 2022 Financial Results; Reaffirms Fiscal Year 2022 Revenue Guidance | Venus Concept
• Venus Concept Receives New FDA 510(k) Clearance for Venus BlissMAX | Venus Concept
• Venus Concept Announces First Patient Treatment in Study Evaluating the Safety and Efficacy of Aime™ Next Generation Robotic Technology for the Treatment of Moderate to Severe Facial Wrinkles | Venus Concept
• Venus Concept to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022 | Venus Concept
• Venus Concept Submits FDA 510(k) Related to the Use of its Aime™ Next Generation Robotic Technology for Tissue Excision and Skin Resurfacing | Venus Concept
• Venus Concept Announces Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 Revenue Guidance | Venus Concept
• Venus Concept Inc. to Present at the Maxim Virtual Growth Conference on March 28th | Venus Concept
• Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16th | Venus Concept
• Venus Concept to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 28, 2022 | Venus Concept
• View more press releases Close

Redes sociales sobre Venus Concept

• Venus Concept en Wikipedia, Google News y Yahoo Finance
• Venus Concept en LinkedIn, Twitter y YouTube